Abiopharma

89bio Presents Positive Results from ENTRIGUE Phase 2 Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) at European Society of Cardiology Congress 2022

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium

Quince Therapeutics to Present at Upcoming Scientific Meetings

Regeneron Announces Investor Conference Presentations

<p>Adaptimmune to Host Live, Virtual Event to Review Phase 1 SURPASS Trial Data and Outline Plans for Further Development in SURPASS Family of Trials</p>

<p>Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium</p>

<p>Horizon Therapeutics plc to Present at the Morgan Stanley 20th Annual Global Healthcare Conference</p>

<p>Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022</p>

<p>Immuneering Announces Participation in September Investor Conferences</p>

Reata Pharmaceuticals Inc. - Corporate Presentation